How cells adapt metabolism to meet demands is an active area of interest across biology. Among a broad range of functions, the polyamine spermidine is needed to hypusinate the translation factor eukaryotic initiation factor 5A (eIF5A). We show here that hypusinated eIF5A (eIF5A H ) promotes the efficient expression of a subset of mitochondrial proteins involved in the TCA cycle and oxidative phosphorylation (OXPHOS). Several of these proteins have mitochondrial targeting sequences (MTSs) that in part confer an increased dependency on eIF5AH. In macrophages, metabolic switching between OXPHOS and glycolysis supports divergent functional fates stimulated by activation signals. In these cells, hypusination of eIF5A appears to be dynamically regulated after activation. Using in vivo and in vitro models, we show that acute inhibition of this pathway blunts OXPHOS-dependent alternative activation, while leaving aerobic glycolysis-dependent classical activation intact. These results might have implications for therapeutically controlling macrophage activation by targeting the polyamine-eIF5A-hypusine axis.
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In Brief
Puleston et al. show that polyamine biosynthesis modulates mitochondrial metabolism through eIF5A hypusination (eIF5A H ). They find that inhibiting the polyamine-eIF5A-hypusine pathway blocks OXPHOS-dependent macrophage alternative activation, while leaving aerobic glycolysis-dependent macrophage classical activation intact. These results might have implications for therapeutically controlling macrophage activation by targeting the polyamineeIF5A-hypusine axis.
SUMMARY
How cells adapt metabolism to meet demands is an active area of interest across biology. Among a broad range of functions, the polyamine spermidine is needed to hypusinate the translation factor eukaryotic initiation factor 5A (eIF5A). We show here that hypusinated eIF5A (eIF5A H ) promotes the efficient expression of a subset of mitochondrial proteins involved in the TCA cycle and oxidative phosphorylation (OXPHOS). Several of these proteins have mitochondrial targeting sequences (MTSs) that in part confer an increased dependency on eIF5AH. In macrophages, metabolic switching between OXPHOS and glycolysis supports divergent functional fates stimulated by activation signals. In these cells, hypusination of eIF5A appears to be dynamically regulated after activation. Using in vivo and in vitro models, we show that acute inhibition of this pathway blunts OXPHOS-dependent alternative activation, while leaving aerobic glycolysis-dependent classical activation intact. These results might have implications for therapeutically controlling macrophage activation by targeting the polyamine-eIF5A-hypusine axis.
INTRODUCTION
Aberrant metabolic rewiring can have pathological consequences. This is evident in cells of the immune system, where metabolic pathways and their metabolites not only provide energy and substrates for growth and survival, but also instruct differentiation, gene expression, and effector functions important
Context and Significance
Macrophages play key physiological roles, including combating infections and cancer. The underlying metabolism of macrophages is linked to their function and modulation of metabolic pathways in immune cells for therapeutic purposes is an active area of investigation. Researchers at the Max Planck Institute in Freiburg, Germany, discovered that a fundamental metabolic pathway (polyamine biosynthesis), which had previously been linked to essential cellular processes, such as DNA repair, is intricately involved in cellular respiration and macrophage function by regulating mitochondrial proteins. Polyamine biosynthesis results in a specific chemical modification (hypusination) of the enzyme eIF5A that regulates a subset of mitochondrial proteins involved in core respiration, thus affecting alternative macrophage activation, a cell type that strongly engages their mitochondria. These results put the polyamine pathway and hypusination on the therapeutic map for immune cells. 
(legend continued on next page)
for host immunity and tissue homeostasis (Buck et al., 2017) . Understanding how immune cells control metabolic pathways, engaging one or dampening another, may provide valuable insight into controlling cellular functions by redirecting metabolism.
Polyamines have roles in cellular proliferation, autophagy, binding DNA, and modulating ion channels (Miller-Fleming et al., 2015; Pegg, 2016) . In eukaryotes, the polyamine spermidine also serves as a substrate for the hypusination of a conserved lysine residue in eukaryotic initiation factor 5A (eIF5A) (Park et al., 1981) by the action of two enzymes, deoxyhypusine synthase (DHPS) and deoxyhypusine hydroxylase (DOHH) (Abbruzzese et al., 1986; Wolff et al., 1995) . There are two isoforms of eIF5A, eIF5A1 (we refer to this isoform as eIF5A in this study), which is expressed ubiquitously, and eIF5A2, which is only expressed in the testes and brain (Jenkins et al., 2001) . Although originally thought to initiate translation, eIF5A H actually promotes general translation elongation and termination (Saini et al., 2009 ) (Schuller et al., 2017) . It has also been linked to the efficient translation of select mRNA subsets (Kang and Hershey, 1994) , such as those containing consecutive proline codons (Gutierrez et al., 2013) , or other sequence-specific properties (Pelechano and Alepuz, 2017). Although polyamine levels are elevated in most cancers, and eIF5A is recognized as a critical regulator of cell growth and tumor development (Nakanishi and Cleveland, 2016) , precisely how these pathways coordinate to support cell metabolism in healthy cells is unclear.
RESULTS
Polyamine Synthesis and Hypusinated eIF5A Modulate OXPHOS To investigate how polyamine biosynthesis ( Figure 1A ) contributes to metabolism we exposed murine embryonic fibroblasts (MEFs) to 2-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase (ODC) (Poulin et al., 1992) , the enzyme that initiates polyamine synthesis, and diethylnorspermine (DENSPM), which induces the spermidine catabolizing enzyme SSAT and spermidine oxidase (Stani c et al., 2009) . Blocking polyamine biosynthesis, or inducing spermidine catabolism, reduced oxygen consumption rates (OCRs) (an indicator of oxidative phosphorylation [OXPHOS] ), while also reducing extracellular acidification rates (ECARs) (an indicator of aerobic glycolysis), although to a lesser extent (Figures 1B, S1A, and S1B). We confirmed a decrease in putrescine, spermidine, and spermine levels in treated cells, whereas the upstream metabolite ornithine was unchanged ( Figure 1C ). An important cellular function of spermidine is to provide a substrate for DHPS, the rate-limiting enzyme during eIF5A H formation (Park et al., 1981 ) ( Figure 1A ). Cells exposed to the DHPS inhibitor GC7 (Melis et al., 2017) , or ciclopirox (CPX), a DOHH inhibitor (Hoque et al., 2009) , also dampened OXPHOS ( Figures 1D and  1E ). Immunoblot with an eIF5A H -specific antibody (Nishiki et al., 2013) confirmed that eIF5A H was decreased after GC7 treatment.
Although pharmacological inhibitors often have off-target effects, which can confound results, they also can permit the acute inhibition of a particular target. As long as results are interpreted cautiously, this approach can be helpful when studying a pathway as central as respiration. Genetic evidence can support inhibitor studies, but also must be interpreted carefully, as genetic models often result in a more chronic deletion, depending on the techniques used to delete a specific gene. With these caveats in mind, we examined the loss of respiration genetically by acutely knocking down components of this pathway. We transduced isopropyl b-D-1-thiogalactopyranoside (IPTG)-inducible Eif5a-small hairpin RNA (shRNA) into MEFs (Figures 1F and S1C) and observed a direct correlation between eIF5A expression and respiration ( Figure 1G ). Cells with tamoxifen-induced deletion of Dhps ( Figure 1H ) displayed a similar loss of OCR (Figure 1I ), while these treatments had varying effects on ECARs (Figures S1D-S1H). Cell viability was unaffected in drug-treated MEFs (data not shown) and in those expressing Eif5a-shRNA for 5 days ( Figure S1I ). Collectively, our results show that dampening any one of several components of the polyamine-eIF5A H pathway, either by acute pharmacological or genetic inhibition, limits OXPHOS, a process conserved across cell types and species ( Figures 1J and S1J ).
Hypusinated eIF5A Maintains Tricarboxylic Acid Cycle and ETC Integrity in Macrophages
To assess the extent of this respiration defect, we exposed MEFs to 2-deoxyglucose, which enforces OXPHOS by limiting glycolysis. MEFs expressing Eif5a-shRNA, or depleted for Dhps, did not compensate by enhancing OCRs compared with controls ( Figures S1K-S1N ), revealing that, when forced, cells with insufficient levels of eIF5A or eIF5A H are unable to promote mitochondrial respiration in this setting. To further probe respiratory function controlled by eIF5A, we generated mouse bonemarrow-derived macrophages (BMM4) and then activated them with interleukin-4 (IL-4) (M(IL-4)). IL-4-driven activation of these cells depends on mitochondrial respiration (Vats et al., 2006) , while lipopolysaccharide (LPS)/interferon g (IFN-g)-driven activation depends on aerobic glycolysis (Tannahill et al., 2013) . Since M(IL-4) and LPS/IFN-g-activated macrophages (M(LPS/ IFN-g)) do not proliferate to an appreciable extent in vitro (Arpa et al., 2009; Liu et al., 2016) , we could assess the role of polyamine biosynthesis on respiration dissociated from its regulation of proliferation ( Figure S1O ) (Thomas and Thomas, 2001 Figure 2C ), indicating that DHPS function, and thus eIF5A H , is needed for TCA cycle engagement.
Incorporation of 13 C-glutamine and palmitate carbons into TCA cycle metabolites was also decreased in GC7-treated cells (Figures 2C and S2D) .
eIF5A
H Ablation Dampens the Expression of Some
Mitochondrial Proteins
To ascertain why TCA cycle flux was inhibited, we performed a proteomics analysis of GC7-treated M(IL-4). Of 153 significantly altered proteins, 63 were mitochondrial, including TCA cycle enzymes and ETC proteins ( Figure 2D and Table S1 ). The one factor that we had uncovered thus far that unified our results was that, on acute pharmacologic or genetic inhibition of any one of several components of the polyamine-eIF5A H pathway, we observed decreased OXPHOS, which was consistent with dysregulated mitochondrial metabolism. We investigated if this perturbation in the mitochondrial proteome highlighted by our proteomic analysis was the cause of defective mitochondrial respiration in the absence of eIF5A H . To validate our proteomics data, we assessed the expression of several mitochondrial enzymes, for which there were high quality commercial antibodies available, in GC7-treated BMM4 ( Figure 2E) Since SDH has a dual role and also participates in the ETC as complex II, we assayed ETC complexes and found that GC7-treated M0 and M(IL-4) and MEFs deleted for Eif5a and Dhps ( Figures 2E and 2F ) had dampened expression of several ETC complex proteins. M(LPS/IFN-g) had decreased expression of these ETC proteins regardless of GC7 treatment ( Figure 2E ). Consistent with decreased TCA cycle metabolites in GC7-treated cells ( Figure 2B ), we observed a partial rescue of respiration on exposure to succinate ( Figure S2L ). Together, these data suggest that the polyamine-eIF5A
H axis supports the expression of a subset of mitochondrial proteins in core respiration, providing a possible explanation as to why cells with decreased eIF5A H have reduced TCA cycle flux and OCRs. We next assessed how eIF5A H might specifically regulate mitochondrial protein expression, and thereby OXHPOS. Although many mitochondrial proteins were strikingly decreased 24 h following GC7 treatment ( Figure 2E ), transcription of the genes encoding these proteins was not diminished 24 h following GC7 treatment ( Figure 3A ), indicating that the TCA cycle defects conferred by reduced eIF5A H were not necessarily a direct reflection of transcriptional changes in these genes. Polyamines and eIF5A are also known to modulate autophagy (Eisenberg et al., 2009; Lubas et al., 2018) , an important process controlling mitochondrial quality (Pickles et al., 2018) . However, M(IL-4) macrophages treated with the autophagy inhibitor bafilomycin A1 displayed normal expression of numerous mitochondrial proteins ( Figure S3A ), suggesting to us that, at least in the context we were investigating, autophagy was not playing a direct role.
Certain MTSs Have an Increased Dependency on eIF5A H
To explore how eIF5A might exert control over the translation of specific mRNAs, we performed polysome analysis of control and Eif5a-shRNA-expressing MEFs. Polysomes are thought to be a major site of active translation (Van Der Kelen et al., 2009 ). We speculated that there might be a selective loss of gene transcripts from polysomes that corresponded to the proteins identified in our proteomics data as displaying a greater dependency on eIF5A H (Table S1 ). Polysome profile analysis revealed reduced polysomes in eIF5A-depleted cells ( Figure 3B ), in line with previously published data and known translation defects on eIF5A ablation (Henderson and Hershey, 2011) . Consistent with reduced polysomes, we observed that the transcripts for eIF5A hyperdependent Sdha and Mcm moved out of the polysome fraction after eIF5A deletion, but the same was true for Idh2 and Gapdh transcripts, two proteins that did not show (C) D-13 C-Glucose and 13 C-glutamine gas chromatography-mass spectrometry trace analysis of M(IL-4) treated with 10 mM GC7 for 24 h. (D) Target sequences were cloned into the N terminus of mCherry fused to a degron (to limit its half-life and circumvent differential MTS mCherry half-life between constructs) separated by a GSGSG flexible linker to allow correct and independent folding of the introduced sequences and mCherry. These were subcloned into the MIGR1 vector and transduced into MEFs (SUCLG1 is a subunit of succinyl-CoA synthetase).
(legend continued on next page) increased dependency on eIF5A H in our experiments ( Figure 3C ). Although these observations were consistent with a role of eIF5A in general translation (Pelechano and Alepuz, 2017; Schuller et al., 2017) , these data did not provide us with further insight into a mechanism of how specific mitochondrial proteins could have an increased dependency on eIF5A for efficient translation, and suggested that differences might occur during translation elongation in monosomes (Heyer and Moore, 2016) .
To approach this question in a targeted fashion, we reasoned that $40% of the proteins we found to be sensitive to eIF5A inhibition were mitochondrial proteins, and therefore contained a MTSs (Table S1 ). MTSs contain motifs, such as stretches of repetitive amino acids or a high frequency of charged residues, which can lead to ribosome stalling and slower translation (Charneski and Hurst, 2013; Sabi and Tuller, 2015) . To test whether MTSs of specific mitochondrial proteins could increase dependency on eIF5A
H for efficient expression we cloned the MTSs of several proteins (SUCLG1, SDHA, and MCM) identified by our proteomic and immunoblot analyses (Table S1 ; Figures 2E and 2F) to be eIF5A H -hyperdependent and fused them to the N terminus of mCherry in MIGR1. We chose these proteins based on them having known MTS sequences that we were able to validate. In the context of these constructs, mCherry expression would rely on the translation of the preceding sequence ( Figures 3D and S3B ). As controls, in place of the MTSs, we positioned a SV40 nuclear localization sequence (NLS) and a control amino acid sequence made up of the first seven residues of GFP at the N terminus of mCherry (herein referred to as ''control'') ( Figure 3D ). For comparison, we examined the MTSs of IDH2 ( Figure S3B ), a protein suggested by our immunoblot analyses to have reduced dependency on eIF5A H ( Figures 2F and S2E) . We imaged cells to confirm that our MTS mCherry constructs localized to mitochondria, and SV40 NLS mCherry to the nucleus ( Figures 3E and S3C ). Next, we transduced these constructs into MEFs and assessed mCherry expression by flow cytometry in the presence of Eif5a-small interfering RNA (siRNA), Dhps-siRNA, to acutely genetically target this pathway, or GC7, for acute pharmacological inhibition. Importantly, internal ribosome entry site (IRES)-driven GFP expression was equivalent in cells transduced with all constructs, and unaffected by genetic or pharmacological deletion of Dhps or Eif5a ( Figure 3F ).
Compared with control cells, or cells exposed to a nontargeted siRNA, mCherry expression dependent on SUCLG1, SDHA, or MCM MTSs was decreased compared with control or NLS mCherry ( Figures 3F, 3G , and S3D). These data suggest that, regardless of a reduction in eIF5A or eIF5A H ( Figure S3E ), the MTSs of these proteins have reduced translation, consistent with our hypothesis that these eIF5A H -dependent mitochondrial proteins have MTSs that could lead to slower/less efficient translation. In contrast, IDH2 MTS mCherry was more highly expressed, in line with IDH2 protein being unaffected by the loss of eIF5A H ( Figure S3D ). When we exposed transduced cells to Eif5a-siRNA, Dhps-siRNA, or GC7 the expression of SUCLG1, SDHA, and MCM MTS mCherry was further abrogated relative to untreated cells or cells exposed to a nontargeted siRNA (Figures 3F , 3G, and S3F). This effect was much less apparent on IDH2 MTSs, SV40 NLS, and control mCherry expression.
To confirm that the MTSs of select mitochondrial proteins contain amino acid sequences that confer eIF5A hyperdependency, we swapped the C terminus half of the IDH2 MTSs for the C terminus half of SUCLG1 MTSs and fused that novel sequence to the N terminus of mCherry. Whereas normal IDH2 MTSs translation exhibited little sensitivity to GC7, the domain swap of C terminus SUCLG1 MTSs resulted in significantly decreased translation in response to GC7 ( Figure S3G ). Normal SUCLG1 MTS translation exhibited high sensitivity to eIF5A H inhibition; however, when we fused the N terminus half of SUCLG1 MTSs to the C terminus half of IDH2 MTSs at the beginning of mCherry, we observed no decrease in translation of this product in response to GC7 ( Figure S3G ). These data suggest that sequences in SUCLG1 MTSs require eIF5A H for optimal translation, while the IDH2 MTS sequence has a comparatively reduced requirement for eIF5A H , explaining the loss of SUCLG1 protein, but normal IDH2 levels during eIF5A H ablation. These observations support our conclusion that, for this set of proteins examined, the MTS sequences lead to slower translation and therefore show increased dependency on eIF5A H , a protein known to facilitate efficient translation of transcripts with specific sequence properties (Pelechano and Alepuz, 2017; Schuller et al., 2017 (legend continued on next page) from polyamine biosynthesis could lead to alterations in eIF5A H levels in immune cells.
Previously, OXPHOS has been implicated in M(IL-4) activation (Huang et al., 2014; Van den Bossche et al., 2016; Vats et al., 2006) . To test this directly we activated BMM4 with IL-4 in the presence or absence of mitochondrial inhibitors. We observed significantly impaired expression of CD206, CD301, and Arg1 during complex I inhibition (with rotenone), complex III inhibition (with antimycin A and myxothiazol), and complex V inhibition (with oligomycin), supporting that mitochondrial respiration is important for macrophage alternative activation ( Figures 4C  and S4B ). We next assessed markers of alternative activation in M(IL-4) on acute eIF5A H inhibition. Reducing eIF5A H blunted RELMa expression ( Figures 4D and S4C) , while GC7 and CPX treatment, or genetic ablation of Eif5a, Dhps, or Dohh, blunted Arg1, CD301, and CD206 to varying degrees (Figures 4D and S4D-S4G), indicating reduced alternative activation, despite intact IL-4 signaling through STAT6 ( Figure S4H ). Proteomics data of GC7-treated M(IL-4) confirmed the decline of many proteins associated with alternative activation, including CD301 ( Figure 2D ; Table S1 ). Human monocyte-derived macrophages exposed to IL-4 also exhibited increased eIF5A H ( Figure S4I) and GC7 treatment potently reduced expression of alternative activation markers in these cells ( Figures 4E and S4J increased, again illustrating that hypusination is a dynamically regulated process in macrophages ( Figure 4F ). Furthermore, the in situ peritoneal accumulation of macrophages in response to IL-4c, a hallmark of alternative activation in vivo (Jenkins et al., 2011) , was diminished in the presence of GC7 ( Figure 4G ). These data support the idea that eIF5A H has a prominent role in macrophages that rely on OXPHOS.
To further test the function of eIF5A H in alternative macrophage activation and protective immunity in vivo, we infected mice with the intestinal helminth parasite Heligmosomoides polygyrus. Mice were pre-treated with IL-4c on days À4, À2, and 0 before infection to drive the expansion of alternatively activated macrophages. Some mice were injected daily with GC7 between days À4 and 0. This experimental design allowed us to more specifically target macrophages without directly affecting the ensuing T cell response. On day 15 after infection we found significantly increased numbers of macrophages in the peritoneal cavity alongside a reduced number of worms in the intestines, and eggs in the feces when mice were pre-treated with IL-4 ( Figures 4H and S4K ). This effect was lost in mice pretreated with GC7, indicating reduced alternative macrophage polarization ( Figures 4H and S4K) . We saw no reduction of the T H 2 response after GC7 (data not shown).
Consistent with the idea that eIF5A H activity is most critical in cells that depend on increased respiration, markers of classical macrophage activation, such as nitric oxide synthase 2 (NOS2), major histocompatibility complex class II (MHCII), and CD86 were unchanged in M(LPS/IFN-g), cells that rely on aerobic glycolysis, following genetic or pharmacological targeting of components of the eIF5A H pathway ( Figures S4L-S4N ). To substantiate these observations in vivo, we injected LPS into the peritoneal cavity of mice to elicit classical macrophage activation. Macrophages from mice coinjected with GC7 maintained CD86, MHCII, NOS2, and serum IL-6 and IL-12 levels similar to those in controls treated with LPS alone ( Figure 4I ). Together these data suggest that classical macrophage activation remained unchanged after GC7 treatment.
DISCUSSION
Many inhibitors have off-target effects; however, they remain valuable tools. Genetic models can also come with caveats, as they usually present a longer-term, more chronic deletion that can confound more proximal effects that occur when a gene is initially deleted. We have taken a broad approach in this study using many compounds and acute genetic deletion models to probe the polyamine-eIF5A H axis. The blend of these approaches has led us to conclude that the polyamine-eIF5A H axis plays a role in regulating mitochondrial respiration, at least in part, by influencing the expression of distinct subset of mitochondrial enzymes. Our findings are supported by a report that genetic and GC7-driven inhibition of eIF5A H silences mitochondria in kidney cells, preventing anoxic cell death and improving kidney transplant outcome (Melis et al., 2017) . Our observations suggest that the MTS we identified as having an increased (B) 13 C-Arginine trace analysis in M0, M(LPS), M(L/g), and M(IL-4). Cells were polarized overnight in SILAC media containing 1.1 mM 13 C arginine ± 2.5 mM DFMO.
(C) Expression of macrophage alternative activation markers assessed by flow cytometry in BMM4 exposed to IL-4 ± 500 nM rotenone (complex I inhibitor) or 5 mM antimycin A (complex III inhibitor) or 200 nM myxothiazol (complex III inhibitor) or 5 mM oligomycin (complex V inhibitor) for 20 h (n = 7). (D) CD301 and RELMa expression assayed by flow cytometry in M(IL-4) treated with 10 mM GC7 or 20 mM CPX for 24 h. (E) Expression of human macrophage alternative activation markers assessed by flow cytometry in human monocyte-derived macrophages exposed to IL-4 ± 10 mM GC7 for 20 h (n = 3 individual donors).
(F) C57BL/6 mice were administered IL-4:aIL-4 complex at 5:25 mg by intraperitoneal (i.p.) injection. 24 h later eIF5A and eIF5A H levels were assessed by flow cytometry in peritoneal macrophages (Ly6G À Ly6C À Siglec-F À F4/80 hi CD11b + ) (n = 5 per group).
(G) Absolute number of peritoneal macrophages elicited from mice treated with IL-4:aIL-4 complex at 5:25 mg on days 2 and 4 ± 10 mg/kg GC7 on days 0-3 (n = 4-5 per group).
(H) C57BL/6 mice were treated with IL-4:aIL-4 complex by i.p. injection at 5:25 mg on days À4, À2, and day 0 ± 10 mg/kg GC7 on days À4 to 0. On day 0, mice were orally infected with H. polygyrus by gavage and absolute counts of peritoneal macrophages and intestinal worm burden were assessed on day 15 postinfection (B = naive control) (n = 6 per group).
(I) Mice were treated with 8 mg/kg LPS ± 10 mg/kg GC7 by i.p. injection, 12-h later serum IL-12 and IL-6 levels were quantified, as were markers of classical macrophage activation in peritoneal macrophages (Ly6G dependency on eIF5A H were expressed less efficiently, denoted by their decreased mCherry expression. These results suggested to us that the selectivity of enhanced eIF5A H dependency, at least in one aspect, might be at the level of translational efficiency. Precisely how eIF5A H mediates this effect is not known. Interestingly, eIF5A has been shown to copurify with mitochondrial proteins (Pereira et al., 2016) , but how the potential mitochondrial targeting of eIF5A might influence our results here is not clear. Both polyamine synthesis and eIF5A expression are augmented in cancer cells (Casero and Marton, 2007; Mathews and Hershey, 2015) . Although these changes were largely thought to be important for driving proliferation, our data suggest tha these alterations might also affect mitochondrial activity in cancer cells. Previous studies have also demonstrated the engagement of polyamine biosynthesis and eIF5A in immune cells (Bevec et al., 1994; Hukelmann et al., 2016; Wang et al., 2011) , and we believe our results here highlight an important function of this pathway in controlling OXPHOS. In line with previous reports (Huang et al., 2014; Van den Bossche et al., 2016; Vats et al., 2006) , we confirm an important role for OXPHOS in macrophage alternative activation. Recent analysis of alternative activation at the mRNA level during ETC complex inhibition suggested that OXPHOS was dispensable for M(IL-4) (Divakaruni et al., 2018) , these observations might imply that OXPHOS regulates M(IL-4) activation in a post-transcriptional manner. At the outset of our study we viewed this pathway to control mitochondrial metabolism, one that may remain on in the basal state, but could also be dynamically regulated to ramp up or down, depending on activation state and needs of the cell. However, our data showing that M0 macrophages have much less eIF5A H than M(IL-4) macrophages at 4, 12, or 24 h after activation suggest that this is not the case, as both cell types seem to have similar expression of mitochondrial enzymes we identify as having an enhanced dependency on eIF5A H . Nevertheless, M(IL-4) have higher respiration rates than M0, perhaps suggesting that eIF5A H has additional effects on other proteins that promote TCA flux and OXPHOS. Indeed, our proteomics study revealed 90 proteins that were hyperdependent on eIF5A H , but were not mitochondrial proteins. More work is needed to determine the full scope of how hypusine and eIF5A influences mitochondrial activity in these cells.
Our data suggested that, at least for the few MTS we studied, sequence-specific properties conferred increased dependency on eIF5AH. Given that the SV40 NLS, which is rich in positively charged residues, is not subject to eIF5A H regulation in this study, it is unlikely that the presence of positively charged residues alone confers specificity. Recent evidence notes that the location of these residues may play a role in regulation by eIF5A H , suggesting that MTS secondary structure or other elements may influence ribosome stalling and hence reliance on eIF5A H (Pelechano and Alepuz, 2017; Schuller et al., 2017 ).
The precise nature of the sequence-specific properties, or any potential structural differences in MTS, or how additional factors modulate the ultimate effect eIF5A H has on their translation, has yet to be determined. We remain interested in the upstream signals that influence the polyamine-eIF5A H pathway in immune cells. We speculate that the enrichment of eIF5A H in M(IL-4) is driven by an upturn in substrate abundance. Increased ornithine in M(IL-4) due to upregulated arginase expression results in enhanced substrate for ODC to generate putrescine, and ultimately spermidine, which can be used to synthesize hypusine. A scenario such as this may mean that, even if expression of polyamine-hypusine enzymes is not altered, hypusine synthesis can be augmented because of increased ornithine, putrescine, and spermidine availability. Overall, our data suggest that arginase expression during macrophage alternative activation serves to promote hypusination to support mitochondrial metabolism.
Arginase is expressed in several immune cell types (Bando et al., 2013; Monticelli et al., 2016; Pesce et al., 2009) , and its expression in macrophages leads to the breakdown of arginine, which acts to deplete arginine from the extracellular environment and thereby inhibit the activation of T cells that depend on this amino acid substrate (Rodríguez et al., 2004) . Since it is known that polyamines are important for cell proliferation, it is possible that cells that deplete arginine, something that cancer cells also do to support their own proliferation, block polyamine biosynthesis in T cells, thereby inhibiting their proliferation. More work will need to be done to determine how upstream substrates such as ornithine influence eIF5A H in immune cells and whether this ultimately influences their function.
Limitations of Study
While our study shows that the polyamine-eIF5A-hypusine axis influences the TCA cycle and mitochondrial respiration, and thus controls macrophage activation, a full understanding of how eIF5A
H affects the expression of specific proteins, and in particular certain MTS, remains to be determined. Our experiments do not delineate whether eIF5A H directly effects translation of certain transcripts, or whether it acts through an indirect mechanism that ultimately affects the expression of certain proteins.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL DETAILS
Mice and Immunizations C57BL/6 (Jax, 000664) and Arg1-YFP C57BL/6 (Jax, 015857) were purchased from Jackson Laboratories. All mice were bred and maintained under specific pathogen free conditions under protocols approved by the Animal Welfare Committee of the Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. Mice used in all in vitro and in vivo experiments were 6-10 weeks of age and were age/sex matched. For infection with H. polygyrus bakeri, mice were infected orally by gavage with 200 infective L3 stage larvae. At day 15 post infection, mice were sacrificed and parasite burdens were measured. To count worms, intestines were removed, opened longitudinally, and placed on to muslin cloth draped on top of a 50 ml tube filled with complete RPMI for 4 h at 37 C. Parasites migrated through the cloth into the tube and were recovered for counting on a dissecting microscope. Parasite eggs were enumerated by soaking feces collected from individual mice in water, then diluting the fecal slurry with saturated sodium chloride and counting under a microscope using a McMaster counting chamber. Long acting IL-4 complex (IL-4c) consisted of a 2:1 molar ratio of recombinant mouse IL-4 (Peprotech, London) and anti-IL-4 mAb (clone 11B11; BioXcell, NH) and was administered by i.p. injection at the times indicated in the figure legend. Each mouse received 5 mg of IL-4 and 25 mg of 11B11, ± 10 mg/kg GC7 (Millipore). PBS was used as a vehicle control. For in vivo studies with LPS we administered 8mg/kg LPS (Sigma) by i.p. injection ± 10 mg/kg GC7. IL-12 and IL-6 quantification was assessed by ELISA (eBioscience) as per the manufacturer's instructions on serum 3 hours after LPS injection.
Cell Culture
Bone marrow cells were differentiated for 7 days into bone marrow macrophages (BMM4) by culturing in complete medium (RPMI 1640 media supplemented with 10% FCS, 2mM L-glutamine, 100 U/mL penicillin/streptomycin) with 20 ng/mL macrophage colonystimulating factor (M-CSF; PeproTech). M(IL-4) were generated with 20 ng/mL IL-4 overnight from day 7 of culture; M(LPS/IFNg) were generated with 20 ng/mL LPS (Sigma) and 50 ng/mL IFN-g (R&D Systems) overnight from day 7 of culture. All drug treatments on BMM4 began from day 7 of culture. N1-guanyl-1 7-diaminoheptane (GC7; Enzo Life Sciences) and ciclopirox (Sigma) were typically used at 10 mM and 20 mM, respectively, unless otherwise stated. Difluoromethyl ornithine (DFMO) and diethylnorspermine (DENSPM; Tocris) were used at 2.5 mM and 50 mM, respectively. Dimethylsuccinate (Sigma) was used at 5mM. DHPS Flox/Flox Cre-ER MEFs,were cultured in complete DMEM (DMEM supplemented with 10% FCS, 2mM L-glutamine, 100 U/mL penicillin/streptomycin) and generated as previously described (P€ allmann et al., 2015) . Cre-ER expression was induced with 1 mM 4-OHT (Sigma) for the indicated time period. NIH3T3 MEFs (purchased from ATCC) stably transduced with Eif5a-shRNA were grown in complete DMEM and Eif5a-shRNA expression was induced with 100 mM isopropyl-b-D-1 thiogalactopyranoside (IPTG, Sigma) for the indicated period of time. Madin-Darby Kidney Canine (MDCK) cells were grown in complete DMEM, as was the human breast adenocarcinoma line MCF-7 but with 0.01mg/ml recombinant human insulin. D. melanogaster Schneider 2 (S2) cells were cultured without CO 2 at 28 C in complete Schneider's Drosophila medium (Gibco; supplemented with 10% FCS, 50 U/mL penicillin/streptomycin, 25% conditioned complete Schneider's medium). To generate human macrophages, we negatively selected monocytes from blood using the manufacturers instructions (Stem Cell). All subjects gave written informed consent in accordance with the Declaration of Helsinki and the study was performed according to the CCI Biometric Bank (IRB approval No. 282/11). Monocytes were differentiated into macrophages with 100 ng/mL human M-CSF (R&D Systems) for 6 days in complete medium (RPMI 1640 media supplemented with 10% FCS, 2mM L-glutamine, 100 U/mL penicillin/streptomycin). On day 6, macrophages were polarised with 20 ng/mL human IL-4 (R&D Systems) and analysed the next day.
METHOD DETAILS
Metabolic Profiling Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were measured using the Seahorse XFe Bioanalyser (Seahorse Bioscience). 8x10 4 BMM4 were added to sea horse 96 well plates on day 7 of culture and analysed in XF media (non-buffered RPMI 1640 containing 25 mM glucose, 2 mM L-glutamine, and 1 mM sodium pyruvate) the following day after cytokine and drug treatment. Prior to analysis, cells were incubated for a minimum of 45 minutes at 37 C in the absence of CO 2 . OCR and ECAR were measured under basal conditions, or after the addition of the following drugs: 1 mM oligomycin, 1.5 mM fluoro-carbonyl cyanide phenylhydrazone (FCCP), 100 nM rotenone, and 1 mM antimycin A (all Sigma). Measurements were taken using a 96 well Extracellular Flux Analyser (Seahorse Bioscience). Metabolite Tracing BMM4 on day 7 of culture were washed and cultured in complete RPMI 1640 (minus glucose or glutamine), supplemented with either 11mM 13 C-glucose or 4mM 13 C-glutamine, for 24 hours. 13 C-palmitate (20 mM) was added to complete RMPI 1640 overnight.
13
C-Argining tracing was performed by culturing cells in SILAC media supplemented with 0.2 mM L-lysine and 1.1 mM 13 C-Arginine for 24 hours. MEFs were washed and cultured in complete DMEM (with 10% dialysed serum, minus glucose or glutamine), supplemented with 25 mM 13 C-glucose or 4 mM 13 C-glutamine, for 24 hours. For harvest, cells were rinsed with cold 0.9% NaCl and metabolites extracted using 1.2 mL of 80% MeOH kept on dry ice. 10 nM norvaline (internal standard) was added. For putrescine detection, metabolites were extracted in 80% MeOH containing 3% formic acid. Following mixing and centrifugation, the supernatant was collected and dried via centrifugal evaporation. Dried metabolite extracts were resuspended in pyridine and derivatized with methoxyamine (sc-263468 Santa Cruz Bio) for 60 minutes at 37 C and subsequently with N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamid, with 1% tert-butyldimethylchlorosilane (375934 Sigma-Aldrich) for 30 minutes at 80 C. Isotopomer distributions were measured using a DB5-MS GC column in a 7890 GC system (Agilent Technologies) combined with a 5977 MS system (Agilent Technologies). Correction for natural isotope abundance and calculation of fractional contribution was performed as described elsewhere (Buescher et al., 2015) . Metabolite Quantification Metabolites were quantified by LC-MS using HILIC Chromatography on an Acquity UPLC BEH Amide column 1.7 mm, 2.1x100 mm (polyamines) or a Luna NH2 column (all other metabolites) on a 1290 Infinity II UHPLC system (Agilent Technologies) combined with targeted detection in a 6495 MS system (Agilent Technologies). Peak areas were normalized to 13 
Retroviral Transduction
In BMM4, bone marrow cells exposed to M-CSF were transduced with luciferase (empty vector) or Eif5a-,Dhps-, or Dohh-expressing retrovirus by centrifugation for 90 minutes in media containing hexadimethrine bromide on day 2 of culture. Transduced cells were subsequently drug or cytokine-treated on day 7 of culture and assayed on day 8, sometimes following sorting on day 6. GFP was used as a marker for transduction in these cells. Targeted mCherry A G-block construct (IDT) containing mCherry fused to the degron from ODC (Kelly et al., 2007) (HGFPPEVEEQDDGTLPMSCA QESGMDRH*) (mCherry deg ) was constructed to reduce half-life of the mCherry fusion protein. Between the cloning sites and mCherry a Gly-Ser-Gly-Ser-Gly flexible linker was included, to allow correct and independent folding of the introduced sequences and mCherry. The mCherry deg was cloned into MSCV-I-GFP using XhoI and EcoRI. MTS, NLS, or control sequences were ordered as G-blocks (IDT) or as phosphorylated oligos containg XhoI and BamHI compatible overhangs and cloned into MSCV-mCherry deg -I-GFP using XhoI and BamHI. The targeted sequences fused to mCherry are denoted in Figure 3 and extended data Figure 3 .
Lentiviral Transductions
The IPTG-inducible MISSION shRNA lentiviral vector pLKO-puro-IPTG-3xLacO was purchased either with a shRNA against the 3 0 -UTR of the murine eIF5A mRNA sequence (custom-made from #SHCLND-NM181582-TRCN0000125229; Sigma) or a corresponding non-target shRNA control (#SHC332-1EA; Sigma). Stable transduction of the lentiviral was performed as previously described (Preukschas et al., 2012) using HEK293T cells, the packaging plasmids: pMDLg/pRRE (Gag/Pol), pRSV-Rev (Rev) and phCMV-VSV-G (envelope) as well as the ProFection Mammalian Transfection System Calcium Phosphate Kit (Promega). Positive cells were selected using puromycin.
